Evidence map›Paper›PMID 41409119›Full record

ArticlePleura and peritoneum2025

The addition of collagenase to BromAc

Carissa Vici, Mathew Eapen, Pooja Narang, David L Morris

Abstract read
In one paragraph

Article in Pleura and peritoneum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carissa ViciPeritonectomy Unit, St George Hospital, South Eastern Sydney Local Health District, Kogarah, NSW, Australia.
Mathew EapenMucpharm Pty. Ltd., Kogarah, NSW, Australia.
Pooja NarangMucpharm Pty. Ltd., Kogarah, NSW, Australia.
David L MorrisPeritonectomy Unit, St George Hospital, South Eastern Sydney Local Health District, Kogarah, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Pseudomyxoma peritonei (PMP) is a rare peritoneal malignancy. BromAc Methods: This preclinical human Results: At 24 h post-treatment, all combinations with collagenase demonstrated almost 100 % dissolution of hard mucin. At 3 and 5 h post-treatment, only BromAc Conclusions: This study provides promising evidence of the efficacy and synergistic effect of combining BromAc

Indexed as

BromAc®collagenasemucinpseudomyxoma peritonei

Identifiers

PMID41409119
PMCPMC12707187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.